S&P 500
(0.19%) 5 109.56 points
Dow Jones
(0.30%) 38 353 points
Nasdaq
(0.24%) 15 966 points
Oil
(-1.41%) $82.67
Gas
(5.72%) $2.03
Gold
(0.14%) $2 350.40
Silver
(-0.05%) $27.52
Platinum
(3.88%) $957.85
USD/EUR
(-0.20%) $0.933
USD/NOK
(-0.33%) $10.99
USD/GBP
(-0.52%) $0.796
USD/RUB
(1.67%) $93.41

实时更新: Photocure ASA [PHO.OL]

交易所: OSE 部门: Pharmaceuticals 工业: Drug Manufacturers—Specialty & Generic
BUY
61.22%
return 17.85%
SELL
26.00%
return 18.15%
最后更新时间29 Apr 2024 @ 22:25

2.35% NOK 56.70

购买 310 min ago

@ NOK56.60

发出时间: 29 Apr 2024 @ 21:39


回报率: 0.18%


上一信号: Apr 29 - 20:30


上一信号: 出售


回报率: 0.00 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:25):
Our systems believe the stock currently is undervalued by 0.37% compare to its pairs and should correct upwards.

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States...

Stats
今日成交量 51 658.00
平均成交量 81 876.00
市值 1.54B
EPS NOK0 ( 2024-02-20 )
下一个收益日期 ( NOK-0.300 ) 2024-05-15
Last Dividend NOK2.00 ( 2013-05-23 )
Next Dividend NOK0 ( N/A )
P/E -45.73
ATR14 NOK1.800 (3.18%)
相关性 (AI algo v.1.1b): Undervalued: 0.37% NOK56.81 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量 相关性

長: 0.75 (moderate)
短: 0.00 (neutral)
Signal:(9) Neutral

Photocure ASA 相关性

10 最正相关
AKH.OL0.929
NAPA.OL0.913
VOLUE.OL0.91
ELABS.OL0.896
NRC.OL0.895
TRVX.OL0.881
ENTRA.OL0.88
EFUEL.OL0.878
XXL.OL0.876
AKRBP.OL0.875
10 最负相关
NAVA.OL-0.921
ENDUR.OL-0.888
NORSE.OL-0.874
NTEL.OL-0.871
ASTK.OL-0.867
BWLPG.OL-0.866
SNI.OL-0.864
SMOP.OL-0.861
AYFIE.OL-0.86
BORR.OL-0.842

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Photocure ASA 相关性 - 货币/商品

The country flag -0.47
( neutral )
The country flag 0.32
( neutral )
The country flag 0.00
( neutral )
The country flag -0.09
( neutral )
The country flag 0.35
( neutral )
The country flag 0.49
( neutral )

Photocure ASA 财务报表

Annual 2023
营收: NOK500.66M
毛利润: NOK446.83M (89.25 %)
EPS: NOK0.00990
FY 2023
营收: NOK500.66M
毛利润: NOK446.83M (89.25 %)
EPS: NOK0.00990
FY 2022
营收: NOK393.13M
毛利润: NOK370.44M (94.23 %)
EPS: NOK-2.66
FY 2021
营收: NOK360.54M
毛利润: NOK336.49M (93.33 %)
EPS: NOK-1.150

Financial Reports:

No articles found.

Photocure ASA Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)
NOK0
(N/A)

Photocure ASA Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.81 - No dividend growth expected in the near future
Information
First Dividend NOK4.00 2009-11-26
Last Dividend NOK2.00 2013-05-23
Next Dividend NOK0 N/A
Payout Date 2013-06-11
Next Payout Date N/A
# dividends 2 --
Total Paid Out NOK6.00 --
Avg. Dividend % Per Year 0.00% --
Score 2.43 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 2.81
Div. Directional Score 7.36 --
Next Divdend (Est)
(2027-03-31)
NOK0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
2.43
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2009 NOK4.00 18.30%
2010 NOK0 0.00%
2011 NOK0 0.00%
2012 NOK0 0.00%
2013 NOK2.00 5.14%
2014 NOK0 0.00%
2015 NOK0 0.00%
2016 NOK0 0.00%
2017 NOK0 0.00%
2018 NOK0 0.00%
2019 NOK0 0.00%
2020 NOK0 0.00%
2021 NOK0 0.00%
2022 NOK0 0.00%
2023 NOK0 0.00%
2024 NOK0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
ALNG.OL Dividend King 2023-11-27 Quarterly 2 6.60% 7.04
OKEA.OL Dividend Knight 2023-12-01 Quarterly 3 5.65% 6.86
SALM.OL Dividend Knight 2023-06-09 Annually 17 2.80% 4.97
BWLPG.OL Dividend Knight 2023-11-17 Quarterly 11 1.68% 4.46
ELK.OL Dividend Knight 2023-05-02 Annually 6 6.64% 4.31
BWO.OL Dividend Knight 2023-11-20 Quarterly 14 0.87% 3.96
ATEA.OL Dividend Knight 2023-11-20 Annually 16 2.97% 3.45
HAFNI.OL Dividend Knight 2023-11-23 Semi-Annually 5 1.18% 3.31
AKER.OL Dividend Knight 2023-11-07 Semi-Annually 20 2.99% 3.13
AUSS.OL Dividend Knight 2023-05-26 Annually 17 3.23% 2.93

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.0005351.5009.9910.00[0 - 0.5]
returnOnAssetsTTM0.0003771.2009.9910.00[0 - 0.3]
returnOnEquityTTM0.0005721.500-1.105-1.657[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM4.800.80010.008.00[1 - 3]
quickRatioTTM4.320.80010.008.00[0.8 - 2.5]
cashRatioTTM3.351.50010.0010.00[0.2 - 2]
debtRatioTTM0.0276-1.5009.54-10.00[0 - 0.6]
interestCoverageTTM1.5351.000-0.543-0.543[3 - 30]
operatingCashFlowPerShareTTM1.9472.009.3510.00[0 - 30]
freeCashFlowPerShareTTM1.4942.009.2510.00[0 - 20]
debtEquityRatioTTM0.0407-1.5009.84-10.00[0 - 2.5]
grossProfitMarginTTM0.9331.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.1311.0009.399.39[0.1 - 0.6]
cashFlowToDebtRatioTTM2.691.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.7040.8008.646.91[0.5 - 2]
Total Score11.91

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM5 606.511.00010.000[1 - 100]
returnOnEquityTTM0.0005722.50-0.710-1.657[0.1 - 1.5]
freeCashFlowPerShareTTM1.4942.009.5010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM1.9472.009.3510.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-238.011.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1051.0009.860[0.1 - 0.5]
Total Score2.81

Photocure ASA

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。